Iron in PDB 4nz2: Crystal Structure of CYP2C9 in Complex with An Inhibitor

Enzymatic activity of Crystal Structure of CYP2C9 in Complex with An Inhibitor

All present enzymatic activity of Crystal Structure of CYP2C9 in Complex with An Inhibitor:
1.14.13.48; 1.14.13.49; 1.14.13.80;

Protein crystallography data

The structure of Crystal Structure of CYP2C9 in Complex with An Inhibitor, PDB code: 4nz2 was solved by G.Branden, T.Sjogren, Y.Xue, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.47 / 2.45
Space group P 3 2 1
Cell size a, b, c (Å), α, β, γ (°) 164.380, 164.380, 111.590, 90.00, 90.00, 120.00
R / Rfree (%) 21.7 / 23.5

Other elements in 4nz2:

The structure of Crystal Structure of CYP2C9 in Complex with An Inhibitor also contains other interesting chemical elements:

Fluorine (F) 6 atoms
Bromine (Br) 2 atoms
Chlorine (Cl) 2 atoms

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of CYP2C9 in Complex with An Inhibitor (pdb code 4nz2). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total 2 binding sites of Iron where determined in the Crystal Structure of CYP2C9 in Complex with An Inhibitor, PDB code: 4nz2:
Jump to Iron binding site number: 1; 2;

Iron binding site 1 out of 2 in 4nz2

Go back to Iron Binding Sites List in 4nz2
Iron binding site 1 out of 2 in the Crystal Structure of CYP2C9 in Complex with An Inhibitor


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of CYP2C9 in Complex with An Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe501

b:32.8
occ:1.00
FE A:HEM501 0.0 32.8 1.0
NA A:HEM501 1.9 33.0 1.0
NC A:HEM501 1.9 32.9 1.0
ND A:HEM501 1.9 33.4 1.0
NB A:HEM501 2.0 32.2 1.0
SG A:CYS435 2.3 37.2 1.0
O A:HOH647 2.3 46.7 1.0
C4B A:HEM501 3.0 32.4 1.0
C1D A:HEM501 3.0 34.1 1.0
C4D A:HEM501 3.0 34.0 1.0
C1C A:HEM501 3.0 32.7 1.0
C1B A:HEM501 3.0 32.4 1.0
C4C A:HEM501 3.0 33.5 1.0
C4A A:HEM501 3.0 32.7 1.0
C1A A:HEM501 3.0 33.4 1.0
CHC A:HEM501 3.3 33.0 1.0
CHD A:HEM501 3.4 34.6 1.0
CHA A:HEM501 3.4 34.2 1.0
CHB A:HEM501 3.4 32.8 1.0
CB A:CYS435 3.4 33.7 1.0
O A:ALA297 4.0 41.8 1.0
CA A:CYS435 4.2 34.4 1.0
C2C A:HEM501 4.2 33.6 1.0
C3C A:HEM501 4.2 34.0 1.0
C2A A:HEM501 4.2 33.7 1.0
C3A A:HEM501 4.2 33.4 1.0
C2D A:HEM501 4.2 34.9 1.0
C2B A:HEM501 4.2 32.3 1.0
C3D A:HEM501 4.2 34.9 1.0
C3B A:HEM501 4.2 32.6 1.0
O A:HOH695 4.6 53.6 1.0
CB A:ALA297 4.7 40.2 1.0
N A:GLY437 4.8 35.8 1.0
C A:ALA297 4.8 42.5 1.0
N A:VAL436 4.9 36.3 1.0
C A:CYS435 4.9 39.3 1.0

Iron binding site 2 out of 2 in 4nz2

Go back to Iron Binding Sites List in 4nz2
Iron binding site 2 out of 2 in the Crystal Structure of CYP2C9 in Complex with An Inhibitor


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 2 of Crystal Structure of CYP2C9 in Complex with An Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Fe501

b:31.8
occ:1.00
FE B:HEM501 0.0 31.8 1.0
NA B:HEM501 1.9 32.0 1.0
ND B:HEM501 1.9 32.3 1.0
NC B:HEM501 2.0 31.7 1.0
NB B:HEM501 2.0 31.2 1.0
SG B:CYS435 2.3 34.2 1.0
O B:HOH755 2.3 42.2 1.0
C1D B:HEM501 3.0 32.9 1.0
C4B B:HEM501 3.0 31.4 1.0
C4D B:HEM501 3.0 32.9 1.0
C1C B:HEM501 3.0 31.5 1.0
C1B B:HEM501 3.0 31.5 1.0
C4A B:HEM501 3.0 31.9 1.0
C1A B:HEM501 3.0 32.5 1.0
C4C B:HEM501 3.0 32.3 1.0
CHC B:HEM501 3.4 32.0 1.0
CB B:CYS435 3.4 30.9 1.0
CHA B:HEM501 3.4 33.2 1.0
CHB B:HEM501 3.4 32.1 1.0
CHD B:HEM501 3.4 33.3 1.0
CA B:CYS435 4.1 31.3 1.0
C2C B:HEM501 4.2 32.3 1.0
C2A B:HEM501 4.2 33.0 1.0
C3A B:HEM501 4.2 32.7 1.0
C3C B:HEM501 4.2 32.6 1.0
O B:ALA297 4.2 36.9 1.0
C2B B:HEM501 4.2 31.6 1.0
C2D B:HEM501 4.2 33.7 1.0
C3D B:HEM501 4.2 33.8 1.0
C3B B:HEM501 4.3 31.7 1.0
O B:HOH682 4.5 55.0 1.0
CB B:ALA297 4.7 35.4 1.0
N B:GLY437 4.8 32.4 1.0
N B:VAL436 4.8 33.8 1.0
C B:CYS435 4.8 36.7 1.0
C B:ALA297 5.0 37.9 1.0

Reference:

G.Branden, T.Sjogren, V.Schnecke, Y.Xue. Structure-Based Ligand Design to Overcome Cyp Inhibition in Drug Discovery Projects. Drug Discov Today V. 19 905 2014.
ISSN: ISSN 1359-6446
PubMed: 24642031
DOI: 10.1016/J.DRUDIS.2014.03.012
Page generated: Sun Dec 13 15:43:23 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy